Betashares Global Royalties ETF (ASX:ROYL)
12.66
+0.09 (0.72%)
At close: Sep 16, 2025
0.72% (1Y)
Assets | 36.04M |
Expense Ratio | 0.69% |
PE Ratio | 27.76 |
Dividend (ttm) | 0.53 |
Dividend Yield | 4.14% |
Ex-Dividend Date | Sep 1, 2025 |
Payout Frequency | Monthly |
Payout Ratio | 115.48% |
1-Year Return | +30.38% |
Volume | 54,294 |
Open | 12.89 |
Previous Close | 12.57 |
Day's Range | 12.60 - 12.89 |
52-Week Low | 9.59 |
52-Week High | 13.34 |
Beta | n/a |
Holdings | 42 |
Inception Date | Sep 9, 2022 |
About ROYL
ROYL.AX was created on 2022-09-09 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The investment objective of the Fund is to provide an investment return that aims to track the performance of the Solactive Global Royalties Index (the Index), before taking into account fees and expenses.
Asset Class Equity
Category Theme
Stock Exchange Australian Securities Exchange
Ticker Symbol ROYL
Provider BetaShares
Index Tracked Solactive Global Royalties Index - AUD - Benchmark TR Net
Performance
ROYL had a total return of 30.38% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.25%.
Top 10 Holdings
75.71% of assetsName | Symbol | Weight |
---|---|---|
Arm Holdings plc | ARM | 11.47% |
WHEATON PRECIOUS METALS CORP | WPM.CT | 11.41% |
FRANCO-NEVADA CORP | FNV.CT | 10.68% |
UNIVERSAL MUSIC GROUP NV | UMG.NA | 9.00% |
GENMAB A/S | GMAB.DC | 8.14% |
Texas Pacific Land Corporation | TPL | 5.87% |
Royal Gold, Inc. | RGLD | 5.61% |
Royalty Pharma plc | RPRX | 5.55% |
Halozyme Therapeutics, Inc. | HALO | 4.28% |
InterDigital, Inc. | IDCC | 3.69% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Sep 1, 2025 | 0.05854 AUD | Sep 16, 2025 |
Aug 1, 2025 | 0.05854 AUD | Aug 18, 2025 |
Jul 1, 2025 | 0.07116 AUD | Jul 16, 2025 |
Jun 2, 2025 | 0.0564 AUD | Jun 18, 2025 |
May 1, 2025 | 0.0564 AUD | May 16, 2025 |
Apr 1, 2025 | 0.0564 AUD | Apr 16, 2025 |